Adoptive immunotherapy for patients with chronic lymphocytic leukaemia using a chimeric antigen receptor targeting CD23

被引：0
|
作者：
Raj, D. [1 ]
Peggs, K. [1 ]
Pule, M. [1 ]
Linch, D. [1 ]
Davies, M. [1 ]
Nathwani, A. [1 ]
机构：
[1] UCL, Dept Haematol, London WC1E 6BT, England
来源：
HUMAN GENE THERAPY | 2011年 / 22卷 / 10期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：A120 / A121
页数：2
相关论文
共 50 条
  • [41] NOTCH2 links protein kinase C delta to the expression of CD23 in chronic lymphocytic leukaemia (CLL) cells
    Hubmann, Rainer
    Duechler, Markus
    Schnabl, Susanne
    Hilgarth, Martin
    Demirtas, Dita
    Mitteregger, Dieter
    Hoelbl, Andrea
    Vanura, Katrina
    Le, Trang
    Look, Thomas
    Schwarzmeier, Josef D.
    Valent, Peter
    Jaeger, Ulrich
    Shehata, Medhat
    BRITISH JOURNAL OF HAEMATOLOGY, 2010, 148 (06) : 868 - 878
  • [42] Prognostic importance of serum soluble CD23 level in chronic lymphocytic leukemia
    Sarfati, M
    Chevret, S
    Chastang, C
    Biron, G
    Stryckmans, P
    Delespesse, G
    Binet, JL
    MerleBeral, H
    Bron, D
    BLOOD, 1996, 88 (11) : 4259 - 4264
  • [43] Chronic lymphocytic leukemia:: HLA class I and CD23 expression.
    Gonzalez-Garcia, C
    Montes-Ares, O
    Majado, MJ
    Montes-Casado, M
    Marín, LA
    Tamayo, M
    Moya-Quiles, R
    Parrado, A
    Alvarez-López, R
    BLOOD, 2002, 100 (11) : 349B - 350B
  • [44] Identification of new phosphorylation sites of CD23 in B-cells of patients with chronic lymphocytic leukemia
    Mad'arova, Martina
    Mucha, Rastislav
    Hresko, Stanislav
    Makarova, Zuzana
    Gdovinova, Zuzana
    Szilasiova, Jarmila
    Vitkova, Marianna
    Guman, Tomas
    Stecova, Natalia
    Dobransky, Tomas
    LEUKEMIA RESEARCH, 2018, 70 : 25 - 33
  • [45] Prognostic significance of expression of CD23 in a population of patients with morphologically atypical chronic lymphocytic leukemia.
    Larson, B
    Lynch, J
    Hei, D
    Rimsza, L
    Braylan, R
    BLOOD, 2000, 96 (11) : 277B - 277B
  • [46] DEVELOPMENT OF A NOVEL CHIMERIC RECEPTOR SPECIFIC FOR THE CD123 ANTIGEN FOR THE TARGETING OF ACUTE MYELOID LEUKAEMIA (AML)
    Tettamanti, S.
    Marin, V.
    Pizzitola, I.
    Magnani, C. F.
    Attianese, G. M. P. Giordano
    Cribioli, E.
    Maltese, F.
    Galimberti, S.
    Lopez, A.
    Biondi, A.
    Bonnet, D.
    Biagi, E.
    PEDIATRIC BLOOD & CANCER, 2013, 60 : 154 - 154
  • [47] Soluble CD23 levels increase following lumiliximab dosing in relapsed chronic lymphocytic leukemia patients
    Harris, Sarah
    Woodworth, James
    Ranuio-Kelley, Julie
    Estrellado, Annalee
    Cesano, Alessandra
    Mu, Hua
    Tangri, Shabnam
    CANCER RESEARCH, 2008, 68 (09)
  • [48] Quantitative expression of CD23 and its ligand CD21 in chronic lymphocytic leukemia
    Lopez-Matas, M
    Rodrigue-Justo, M
    Morilla, R
    Catovsky, D
    Matutes, E
    HAEMATOLOGICA, 2000, 85 (11) : 1140 - 1145
  • [49] Adoptive T-cell Immunotherapy of Cancer Using Chimeric Antigen Receptor-Grafted T Cells
    David Marc Davies
    John Maher
    Archivum Immunologiae et Therapiae Experimentalis, 2010, 58 : 165 - 178
  • [50] Adoptive T-cell Immunotherapy of Cancer Using Chimeric Antigen Receptor-Grafted T Cells
    Davies, David Marc
    Maher, John
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2010, 58 (03) : 165 - 178
12345